Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy.

Saved in:
Bibliographic Details
Title: Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy.
Authors: Dai S; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai, 200032, China., Chen Y; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai, 200032, China., Cai W; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai, 200032, China., Dong S; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai, 200032, China., Zhao J; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shaoxing Central Hospital, Shaoxing, 312030, China.; Department of Oncology, The Central Affiliated Hospital, Shaoxing University, Shaoxing, 312030, China., Chen L; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. lianyu-chen@alu.fudan.edu.cn.; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai, 200032, China. lianyu-chen@alu.fudan.edu.cn., Cheng CS; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. natcheng@connect.hku.hk.; Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong-An Road, Shanghai, 200032, China. natcheng@connect.hku.hk.
Source: Journal of hematology & oncology [J Hematol Oncol] 2025 Sep 26; Vol. 18 (1), pp. 85. Date of Electronic Publication: 2025 Sep 26.
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1756-8722
DOI:10.1186/s13045-025-01739-6